Effect of Kashmaryadi Kwath Virechana in treatment of Vatarakta (Gout)

A clinical study to evaluate the efficacy of virechana karma with kashmaryadi kwath in the management of vatarakta (gout)

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047191

Enrollment

Registered

2022-11-10

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Subjects presenting with clinical features of vatarakta. 2 Patient having chronicity less than 1 year. 3 Subjects of both sex between the age group of 20 to 60 years. 4 Patient having serum uric acid level above 5 mg/dl and presenting the sign and symptoms of vatarakta.

Exclusion criteria

Exclusion criteria: 1 Subjects with uncontrolled metabolic disorders and other systemic disorders 2 Subjects with autoimmune diseases of joints 3 chronicity for more than 1 year.

Design outcomes

Primary

Measure	Time frame
Subjective Parameters 1 Pain (Ruka) VAS Scale 2 Burning Sensation (Daha) 3 Malaise (Angmarda) 4 Local Colour Changes in the Skin Objective Parameters 1 Tenderness (Sparshasahyata) 2 Edema (Shwayathu) 3 Walking Ability 4 Peripheral PulsesTimepoint: 45 Days	—

Secondary

Measure	Time frame
To find out the efficacy of treatment in 30 patients with the help of PAIN VAS SCALE, Burning Sensation (Daha), Malaise (Angmarda), Local Colour Changes in the Skin & Tenderness (Sparshasahyata), Edema (Shwayathu), Walking Ability, Peripheral Pulses.Timepoint: 45 days	—

Countries

India

Contacts

Public ContactSunil Baloda

UPGIAS&R, DSRRAU, Jodhpur

atreyagyan@gmail.com9829798701

Outcome results